297 related articles for article (PubMed ID: 26458400)
1. Small ubiquitin-related modifier 2/3 interacts with p65 and stabilizes it in the cytoplasm in HBV-associated hepatocellular carcinoma.
Liu J; Sha M; Wang Q; Ma Y; Geng X; Gao Y; Feng L; Shen Y; Shen Y
BMC Cancer; 2015 Oct; 15():675. PubMed ID: 26458400
[TBL] [Abstract][Full Text] [Related]
2. SUMOylation of HSP27 by small ubiquitin-like modifier 2/3 promotes proliferation and invasion of hepatocellular carcinoma cells.
Ge H; Du J; Xu J; Meng X; Tian J; Yang J; Liang H
Cancer Biol Ther; 2017 Aug; 18(8):552-559. PubMed ID: 28665748
[TBL] [Abstract][Full Text] [Related]
3. Small ubiquitin-related modifier 1 is involved in hepatocellular carcinoma progression via mediating p65 nuclear translocation.
Liu J; Tao X; Zhang J; Wang P; Sha M; Ma Y; Geng X; Feng L; Shen Y; Yu Y; Wang S; Fang S; Shen Y
Oncotarget; 2016 Apr; 7(16):22206-18. PubMed ID: 26993772
[TBL] [Abstract][Full Text] [Related]
4. Mesencephalic Astrocyte-Derived Neurotrophic Factor Inhibits Liver Cancer Through Small Ubiquitin-Related Modifier (SUMO)ylation-Related Suppression of NF-κB/Snail Signaling Pathway and Epithelial-Mesenchymal Transition.
Liu J; Wu Z; Han D; Wei C; Liang Y; Jiang T; Chen L; Sha M; Cao Y; Huang F; Geng X; Yu J; Shen Y; Wang H; Feng L; Wang D; Fang S; Wang S; Shen Y
Hepatology; 2020 Apr; 71(4):1262-1278. PubMed ID: 31469428
[TBL] [Abstract][Full Text] [Related]
5. Interplay between SUMO1-related SUMOylation and phosphorylation of p65 promotes hepatocellular carcinoma progression.
Jiang C; Zhang C; Dai M; Wang F; Xu S; Han D; Wang Y; Cao Y; Liang Y; Zhang Z; Yan L; Shen Y; He K; Shen Y; Liu J
Biochim Biophys Acta Mol Cell Res; 2024 Jan; 1871(1):119595. PubMed ID: 37730133
[TBL] [Abstract][Full Text] [Related]
6. SUMO2 and SUMO3 transcription is differentially regulated by oxidative stress in an Sp1-dependent manner.
Sang J; Yang K; Sun Y; Han Y; Cang H; Chen Y; Shi G; Wang K; Zhou J; Wang X; Yi J
Biochem J; 2011 Apr; 435(2):489-98. PubMed ID: 21291420
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of SUMO2 inhibits hepatocellular carcinoma cell proliferation, migration and invasion.
Chen J; Chen C; Lin Y; Su Y; Yu X; Jiang Y; Chen Z; Ke S; Lin S; Chen L; Zhang Z; Zhang T
FEBS Open Bio; 2021 Jun; 11(6):1771-1784. PubMed ID: 33989451
[TBL] [Abstract][Full Text] [Related]
8. p65/miR-23a/CCL22 axis regulated regulatory T cells recruitment in hepatitis B virus positive hepatocellular carcinoma.
Li ZQ; Wang HY; Zeng QL; Yan JY; Hu YS; Li H; Yu ZJ
Cancer Med; 2020 Jan; 9(2):711-723. PubMed ID: 31769216
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of toll-like receptor 4 induces suppressive effects on hepatitis B virus-related hepatocellular carcinoma via ERK1/2 signaling.
Wang Y; Cai J; Zeng X; Chen Y; Yan W; Ouyang Y; Xiao D; Zeng Z; Huang L; Liu A
BMC Cancer; 2015 Oct; 15():821. PubMed ID: 26514586
[TBL] [Abstract][Full Text] [Related]
10. SENP3 regulates the global protein turnover and the Sp1 level via antagonizing SUMO2/3-targeted ubiquitination and degradation.
Wang M; Sang J; Ren Y; Liu K; Liu X; Zhang J; Wang H; Wang J; Orian A; Yang J; Yi J
Protein Cell; 2016 Jan; 7(1):63-77. PubMed ID: 26511642
[TBL] [Abstract][Full Text] [Related]
11. Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis.
Pang R; Lee TK; Poon RT; Fan ST; Wong KB; Kwong YL; Tse E
Gastroenterology; 2007 Mar; 132(3):1088-103. PubMed ID: 17383430
[TBL] [Abstract][Full Text] [Related]
12. MKL1 regulates hepatocellular carcinoma cell proliferation, migration and apoptosis via the COMPASS complex and NF-κB signaling.
Liu Z; Sun J; Li C; Xu L; Liu J
BMC Cancer; 2021 Nov; 21(1):1184. PubMed ID: 34742274
[TBL] [Abstract][Full Text] [Related]
13. SUMOylated CPAP is required for IKK-mediated NF-κB activation and enhances HBx-induced NF-κB signaling in HCC.
Yang ST; Yen CJ; Lai CH; Lin YJ; Chang KC; Lee JC; Liu YW; Chang-Liao PY; Hsu LS; Chang WC; Hung WC; Tang TK; Liu YW; Hung LY
J Hepatol; 2013 Jun; 58(6):1157-64. PubMed ID: 23369793
[TBL] [Abstract][Full Text] [Related]
14. Circular RNA circRNF13 inhibits proliferation and metastasis of nasopharyngeal carcinoma via SUMO2.
Mo Y; Wang Y; Zhang S; Xiong F; Yan Q; Jiang X; Deng X; Wang Y; Fan C; Tang L; Zhang S; Gong Z; Wang F; Liao Q; Guo C; Li Y; Li X; Li G; Zeng Z; Xiong W
Mol Cancer; 2021 Aug; 20(1):112. PubMed ID: 34465340
[TBL] [Abstract][Full Text] [Related]
15. [Expression of Raf kinase inhibitor protein and its significance in invasion and metastasis of hepatocellular carcinoma].
Wu XH; Wang SX; Yang YJ; Li JK; Xu Z; Tang RF
Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):358-62. PubMed ID: 21875465
[TBL] [Abstract][Full Text] [Related]
16. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.
Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K
J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004
[TBL] [Abstract][Full Text] [Related]
17. [SUMO-2/3 can covalently bind to progesterone receptor B to regulate its transcriptional activity].
Han BY; Li FC; Cheng L; Xu XJ; Jiang K; Fu J; Han YJ; Lv ZH; Dou JT; Zhang H; Ye QN
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Sep; 31(9):1493-7. PubMed ID: 21945751
[TBL] [Abstract][Full Text] [Related]
18. Post-translational modification of the RhoGTPase activating protein 21, ARHGAP21, by SUMO2/3.
Bigarella CL; Ferro KP; Barcellos KS; Martins-de-Souza D; Traina F; Novello JC; Saad ST; Archangelo LF
FEBS Lett; 2012 Sep; 586(19):3522-8. PubMed ID: 22922005
[TBL] [Abstract][Full Text] [Related]
19. [Expression characteristics of nuclear factor kappa B in hepatocellular carcinoma tissues].
Zhou WM; Ping JL; Qian FC; Zhang GL
Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):843-6. PubMed ID: 19958645
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma.
Wei X; Tan C; Tang C; Ren G; Xiang T; Qiu Z; Liu R; Wu Z
Cell Signal; 2013 May; 25(5):1037-43. PubMed ID: 23376496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
